Dong LM, Kristal AR, Peters U, Schenk JM, Sanchez CA, Rabinovitch PS, et al. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study. Nutr Cancer 2008;60(1):39-48 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/18444134.
Compare quality appraisals for each clinical question
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
- Are there groups of patients with BO that can be discharged from surveillance?